GlassScriptPhysician profile
Anwar Ahmed
NPI 1063528735
$6,434.67
in general payments reported to CMS, 2019-2025
17 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,531 · 2021: $157 · 2022: $2,845 · 2023: $68.34 · 2024: $322 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $2,397.11 | 2019-2025 | Austedo Xr, Austedo Xr |
| Biogen, INC. | $1,731.46 | 2022 | |
| Insightec,INC | $1,092.74 | 2022 | |
| Neurocrine Biosciences, INC. | $320.82 | 2024-2025 | Ingrezza |
| Abbott Laboratories | $288.60 | 2021-2025 | Infinity |
| Ipsen Biopharmaceuticals, INC | $115.00 | 2024 | Dysport |
| Acorda Therapeutics, INC | $106.27 | 2019 | |
| Abbvie INC. | $89.28 | 2024-2025 | |
| Genentech USA, INC. | $72.56 | 2019 | |
| Boston Scientific Corporation | $59.68 | 2019-2021 | |
| Averitas Pharma INC. | $44.11 | 2024 | Qutenza |
| Ge Healthcare | $36.53 | 2023 | |
| Microtransponder, INC. | $35.90 | 2024 | |
| Amgen INC. | $24.04 | 2024 | Uplizna |
| Kyowa Kirin, INC. | $20.57 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anwar Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.